相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go
Meng Lv et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
Epstein - Barr virus - associated Diseases in Allogeneic Hematopoietic Stem Cell Transplantation
Xiu-li Wu et al.
Journal of Hematology & Oncology (2012)
Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemia
Huan Chen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
Li Xuan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
Strategies to Prevent EBV Reactivation and Posttransplant Lymphoproliferative Disorders (PTLD) after Allogeneic Stem Cell Transplantation in High-Risk Patients
Nishitha Reddy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Helen E. Heslop et al.
BLOOD (2010)
Treatment advances in posttransplant lymphoproliferative disease
Courtney D. DiNardo et al.
CURRENT OPINION IN HEMATOLOGY (2010)
The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders
Anna Merlo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation
Q. -F. Liu et al.
TRANSPLANT INFECTIOUS DISEASE (2010)
A Prospective Study on Modulation of Immunosuppression for Epstein-Barr Virus Reactivation in Pediatric Patients Who Underwent Unrelated Hematopoietic Stem-Cell Transplantation
Simone Cesaro et al.
TRANSPLANTATION (2010)
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
Ola Landgren et al.
BLOOD (2009)
Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute
H-A Hou et al.
BONE MARROW TRANSPLANTATION (2009)
Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia
J. Styczynski et al.
BONE MARROW TRANSPLANTATION (2009)
The late adverse events of rituximab therapy - rare but there!
Ron Ram et al.
LEUKEMIA & LYMPHOMA (2009)
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction
H. Omar et al.
TRANSPLANT INFECTIOUS DISEASE (2009)
Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases
J. Styczynski et al.
TRANSPLANT INFECTIOUS DISEASE (2009)
Preemptive Management of Epstein-Barr Virus Reactivation After Hematopoietic Stem-Cell Transplantation
Imran Ahmad et al.
TRANSPLANTATION (2009)
The influence of infection early after allogeneic stem cell transplantation on the risk of leukemic relapse and graft-versus-host disease
Sung-Yong Kim et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab?
A. Buser et al.
BONE MARROW TRANSPLANTATION (2008)
Novel strategies for relapsed and refractory acute myeloid leukemia
Anthony R. Mato et al.
CURRENT OPINION IN HEMATOLOGY (2008)
Epstein-Barr viral load and disease prediction in a large cohort of allogeneic stem cell transplant recipients
S. M. Aalto et al.
CLINICAL INFECTIOUS DISEASES (2007)
Retrospective evaluation of serum Epstein Barr virus DNA levels in 406 allogeneic stem cell transplant patients
Eeva Juvonen et al.
HAEMATOLOGICA (2007)
Chronic GvHD decreases antiviral immune responses in allogeneic BMT
Mohammad S. Hossain et al.
BLOOD (2007)
Treatment and outcomes of post-transplant lymphoproliferative disease: A single institution study
Francis K. Buadi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction
Amelie Kinch et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2007)
Psychiatric symptoms and cognitive dysfunction caused by Epstein-Barr virus-induced encephalitis
Joachim Behr et al.
EUROPEAN PSYCHIATRY (2006)
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders:: results of a prospective multicenter phase 2 study
S Choquet et al.
BLOOD (2006)
Reconstitution of lymphocyte subpopulations in children with inherited metabolic storage diseases after haematopoietic cell transplantation
P Corti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Quantification of Epstein-Barr virus load in Argentinean transplant recipients using real-time PCR
J Yancoski et al.
JOURNAL OF CLINICAL VIROLOGY (2004)
Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation
JWJ van Esser et al.
BLOOD (2002)
Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease
BC Gärtner et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Diagnosis and treatment of posttransplantation lymphoproliferative disease after hematopoietic stem cell transplantation
HJ Wagner et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Prospective monitoring of the Epstein-Barr virus DNA by a real-time quantitative polymerase chain reaction after allogenic stem cell transplantation
Y Hoshino et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT
JWJ van Esser et al.
BLOOD (2001)
An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs
S Gottschalk et al.
BLOOD (2001)
分享论文
